182 related articles for article (PubMed ID: 37961535)
1. Engineered immunomodulatory extracellular vesicles derived from epithelial cells acquire capacity for positive and negative T cell co-stimulation in cancer and autoimmunity.
Kugeratski FG; LeBleu VS; Dowlatshahi DP; Sugimoto H; Arian KA; Fan Y; Huang L; Wells D; Lilla S; Hodge K; Zanivan S; McAndrews KM; Kalluri R
bioRxiv; 2023 Nov; ():. PubMed ID: 37961535
[TBL] [Abstract][Full Text] [Related]
2. Murine Leukemia-Derived Extracellular Vesicles Elicit Antitumor Immune Response.
Pando A; Fast L; Dubielecka PM; Chorzalska A; Wen S; Reagan J
J Blood Med; 2021; 12():277-285. PubMed ID: 34040472
[TBL] [Abstract][Full Text] [Related]
3. Engineered extracellular vesicles for concurrent Anti-PDL1 immunotherapy and chemotherapy.
Chen Y; Wang L; Zheng M; Zhu C; Wang G; Xia Y; Blumenthal EJ; Mao W; Wan Y
Bioact Mater; 2022 Mar; 9():251-265. PubMed ID: 34820569
[TBL] [Abstract][Full Text] [Related]
4. Immune engineered extracellular vesicles to modulate T cell activation in the context of type 1 diabetes.
Becker MW; Peters LD; Myint T; Smurlick D; Powell A; Brusko TM; Phelps EA
Sci Adv; 2023 Jun; 9(22):eadg1082. PubMed ID: 37267353
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated Fibroblast-derived Extracellular Vesicles Mediate Immune Escape of Bladder Cancer via PD-L1/PD-1 Expression.
Feng R; Li Z; Ge G; Wang C; Jia Y; Ouyang J
Endocr Metab Immune Disord Drug Targets; 2023; 23(11):1410-1420. PubMed ID: 36852791
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Dendritic Cell Maturation and Function.
Reis M; Mavin E; Nicholson L; Green K; Dickinson AM; Wang XN
Front Immunol; 2018; 9():2538. PubMed ID: 30473695
[TBL] [Abstract][Full Text] [Related]
7. Thermally engineered MSC-derived extracellular vesicles ameliorate colitis in mice by restoring the imbalanced Th17/Treg cell ratio.
Tang D; Liu M; Gao S; Sun H; Peng Y; Li Y; Wang Y; Wang X; Chen H
Int Immunopharmacol; 2023 Dec; 125(Pt A):111077. PubMed ID: 38149575
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles from human umbilical cord blood plasma modulate interleukin-2 signaling of T cells to ameliorate experimental autoimmune encephalomyelitis.
Kim S; Maeng JY; Hyun SJ; Sohn HJ; Kim SY; Hong CH; Kim TG
Theranostics; 2020; 10(11):5011-5028. PubMed ID: 32308765
[TBL] [Abstract][Full Text] [Related]
9. Tumor-derived extracellular vesicles containing microRNA-1290 promote immune escape of cancer cells through the Grhl2/ZEB1/PD-L1 axis in gastric cancer.
Liang Y; Liu Y; Zhang Q; Zhang H; Du J
Transl Res; 2021 May; 231():102-112. PubMed ID: 33321257
[TBL] [Abstract][Full Text] [Related]
10. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles.
Ricklefs FL; Alayo Q; Krenzlin H; Mahmoud AB; Speranza MC; Nakashima H; Hayes JL; Lee K; Balaj L; Passaro C; Rooj AK; Krasemann S; Carter BS; Chen CC; Steed T; Treiber J; Rodig S; Yang K; Nakano I; Lee H; Weissleder R; Breakefield XO; Godlewski J; Westphal M; Lamszus K; Freeman GJ; Bronisz A; Lawler SE; Chiocca EA
Sci Adv; 2018 Mar; 4(3):eaar2766. PubMed ID: 29532035
[TBL] [Abstract][Full Text] [Related]
11. Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression.
Doeppner TR; Herz J; Görgens A; Schlechter J; Ludwig AK; Radtke S; de Miroschedji K; Horn PA; Giebel B; Hermann DM
Stem Cells Transl Med; 2015 Oct; 4(10):1131-43. PubMed ID: 26339036
[TBL] [Abstract][Full Text] [Related]
12. Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma.
Serratì S; Di Fonte R; Porcelli L; De Summa S; De Risi I; Fucci L; Ruggieri E; Marvulli TM; Strippoli S; Fasano R; Rafaschieri T; Guida G; Guida M; Azzariti A
J Exp Clin Cancer Res; 2023 Sep; 42(1):251. PubMed ID: 37759291
[TBL] [Abstract][Full Text] [Related]
13. Novel antitumor therapeutic strategy using CD4
Shin S; Jung I; Jung D; Kim CS; Kang SM; Ryu S; Choi SJ; Noh S; Jeong J; Lee BY; Park JK; Shin J; Cho H; Heo JI; Jeong Y; Choi SH; Lee SY; Baek MC; Yea K
Biomaterials; 2022 Oct; 289():121765. PubMed ID: 36067566
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of T-cell-suppressive PD-L1
Baur R; Karl F; Böttcher-Loschinski R; Stoll A; Völkl S; Gießl A; Flamann C; Bruns H; Schlötzer-Schrehardt U; Böttcher M; Schewe DM; Fischer T; Jitschin R; Mackensen A; Mougiakakos D
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36898735
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles produced by immunomodulatory cells harboring OX40 ligand and 4-1BB ligand enhance antitumor immunity.
Semionatto IF; Palameta S; Toscaro JM; Manrique-Rincón AJ; Ruas LP; Paes Leme AF; Bajgelman MC
Sci Rep; 2020 Sep; 10(1):15160. PubMed ID: 32939048
[TBL] [Abstract][Full Text] [Related]
16. Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma.
Serratì S; Guida M; Di Fonte R; De Summa S; Strippoli S; Iacobazzi RM; Quarta A; De Risi I; Guida G; Paradiso A; Porcelli L; Azzariti A
Mol Cancer; 2022 Jan; 21(1):20. PubMed ID: 35042524
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells and M2 macrophage play an important role in suppression of Th2-mediated inflammation by adipose stem cells-derived extracellular vesicles.
Cho KS; Kang SA; Kim SD; Mun SJ; Yu HS; Roh HJ
Stem Cell Res; 2019 Aug; 39():101500. PubMed ID: 31344653
[TBL] [Abstract][Full Text] [Related]
18. Role of mesenchymal stem cell derived extracellular vesicles in autoimmunity: A systematic review.
Wang JH; Liu XL; Sun JM; Yang JH; Xu DH; Yan SS
World J Stem Cells; 2020 Aug; 12(8):879-896. PubMed ID: 32952864
[TBL] [Abstract][Full Text] [Related]
19. Preparation of engineered extracellular vesicles with full-length functional PD-1 membrane proteins by baculovirus expression system.
Ishikawa R; Yoshida S; Sawada SI; Sasaki Y; Akiyoshi K
Biochem Biophys Res Commun; 2020 Jun; 526(4):967-972. PubMed ID: 32299612
[TBL] [Abstract][Full Text] [Related]
20. Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine.
Monguió-Tortajada M; Roura S; Gálvez-Montón C; Pujal JM; Aran G; Sanjurjo L; Franquesa M; Sarrias MR; Bayes-Genis A; Borràs FE
Theranostics; 2017; 7(2):270-284. PubMed ID: 28042333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
